Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Why Rheumatologists Should Focus on Patients’ Cardiovascular Health

Simon M. Helfgott, MD  |  Issue: July 2016  |  July 10, 2016

The lipid paradox may also extend to the location of excess body fat. Fat cells are not created equally. Researchers are beginning to embrace the concept of good fat and bad fat. Although the release of inflammatory molecules from visceral fat is considered to be a key factor in the development of the metabolic syndrome, these adverse effects are either not observed or are much less pronounced in adults with only excess subcutaneous fat.11 When it comes to inflicting havoc on our health, what seems to matter most is whether fat cells are taking up residence in visceral organs, such as the liver, or merely depositing themselves under the skin. For example, the relatively rapid metabolic improvement noted following bariatric surgery likely reflects the post-operative loss of visceral fat, because in most cases, it occurs prior to any significant loss of subcutaneous fat and body weight.

A Final Paradox

From an evolutionary standpoint, is there any advantage for a host to be afflicted with the metabolic syndrome? Perhaps.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

In one study, a high-fat diet induced the metabolic syndrome, but also protected the CD-1 mouse strain from the lethality associated with Trypanosoma cruzi infection, dramatically decreasing mortality by 65%.12 It is conceivable that at an earlier point in evolution, the metabolic syndrome conferred a substantial benefit to our survival as a species, as our early ancestors warded off a raft of infectious challenges. Over time, this benefit has been far overshadowed by the syndrome’s downsides.

But all may not be lost. There may be one more lipid paradox to consider. Despite meeting clinical criteria for type 2 diabetes and metabolic syndrome, hibernating animals demonstrate no pathologic consequences of their brief bout with obesity. After shedding their extra fat during the winter fast, animals are able to immediately enter into the reproductive cycle. Nor are the ill effects of circumannual obesity transient; in one Swedish study, atherosclerotic lesions were entirely absent from the major vessels of obese, insulin-resistant hibernators despite marked hyperlipidemia.13 Similarly, obese hibernators fail to develop the smoldering inflammation that characterizes human obesity, despite similar metabolic parameters. The absence of pathology despite remarkably similar metabolic states suggests that transient obesity and insulin resistance are not necessarily pathologic and may, in fact, be part of an adaptive, evolutionarily conserved response to excess nutrient storage.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

That may be the solution! Consider the option of hibernating this fall. With the anticipated pandemonium of the upcoming U.S. general election, imagine if we could hibernate just like our ursine cousins. Pack in those calories, party like it’s 1999, and then take a nap. A very long nap. Yes, you can have your cake and eat it, too.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:OpinionPractice SupportRheuminationsSpeak Out Rheum Tagged with:cardiovascularhypertensionmetabolic syndromeObesitypatient carePractice ManagementRheumatic Diseaserheumatologist

Related Articles

    Cardiovascular Risk in Tocilizumab Therapy for RA

    September 15, 2015

    Observation and research have confirmed that patients with rheumatoid arthritis (RA) are at greater risk of cardiovascular disease than their peers of similar age and gender, and that traditional risk factors and chronic inflammation associated with RA apparently play a significant role in that risk. However, predicting which patients with rheumatoid arthritis are at greater…

    Cardiovascular Risks & Insights from ACR Convergence 2021

    December 9, 2021

    Experts share insights into how LDL & HDL levels are affected by inflammation & the treatment of rheumatic disease, addressing how targeting these levels may improve cardiovascular outcomes for patients.

    Cholesterol Levels in Patients with RA Starting Methotrexate

    February 25, 2016

    Although research regarding the increased cardiovascular (CV) morbidity and mortality in rheumatoid arthritis (RA) has burgeoned in recent years, the need remains for a better understanding of the effects of widely used DMARDs on CV risk and risk factors in RA patients. These authors set out to evaluate the long-term changes in cholesterol levels in patients with early RA. Decreases in RA disease activity over long-term follow-up were associated with increases in cholesterol levels in patients with early RA treated with either biologic or nonbiologic therapies…

    A Heart In Danger

    November 1, 2006

    Rheumatologists should monitor and aggressively treat cardiac risk factors in patients with lupus and rheumatoid arthritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences